Skip to content

IMMUNOVANT, INC.

IMVT

CIK 0001764013

← back to feed
Revenue (TTM)
—
FY May 2026
Net Income (TTM)
−$468.87M
−22.2% YoY FY May 2026
EPS Diluted (TTM)
−$2.81
−1.5% YoY FY May 2026
Gross Margin
—
FY May 2026
Operating Margin
—
FY May 2026
Net Margin
—
FY May 2026
Free Cash Flow (TTM)
−$307.07M
FY May 2026
Cash
$902.11M
FY May 2026
Total Debt
—
FY May 2026
Shares Outstanding
205.31M sh
FY May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings